Connection

Makoto Ohtake to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Makoto Ohtake has written about Xenograft Model Antitumor Assays.
Makoto Ohtake
Connection Strength
0.247
Xenograft Model Antitumor Assays
  1. Hyperthermia and chemotherapy using Fe(Salen) nanoparticles might impact glioblastoma treatment. Sci Rep. 2017 02 20; 7:42783.
    View in: PubMed
    Score: 0.134
  2. A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma. Cancer Res. 2020 12 01; 80(23):5330-5343.
    View in: PubMed
    Score: 0.043
  3. Simultaneous hyperthermia-chemotherapy effect by arterial injection of Fe(Salen) for femur tumor. Cancer Sci. 2019 Jan; 110(1):356-365.
    View in: PubMed
    Score: 0.038
  4. Transient receptor potential cation 3 channel regulates melanoma proliferation and migration. J Physiol Sci. 2017 Jul; 67(4):497-505.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.